Shiv Kumar Sarin

62.2k total citations · 7 hit papers
735 papers, 22.6k citations indexed

About

Shiv Kumar Sarin is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, Shiv Kumar Sarin has authored 735 papers receiving a total of 22.6k indexed citations (citations by other indexed papers that have themselves been cited), including 513 papers in Hepatology, 493 papers in Epidemiology and 196 papers in Surgery. Recurrent topics in Shiv Kumar Sarin's work include Liver Disease Diagnosis and Treatment (413 papers), Liver Disease and Transplantation (341 papers) and Hepatitis B Virus Studies (141 papers). Shiv Kumar Sarin is often cited by papers focused on Liver Disease Diagnosis and Treatment (413 papers), Liver Disease and Transplantation (341 papers) and Hepatitis B Virus Studies (141 papers). Shiv Kumar Sarin collaborates with scholars based in India, United States and Germany. Shiv Kumar Sarin's co-authors include Barjesh Chander Sharma, Praveen Sharma, Ashish Kumar, Manoj Kumar, Puja Sakhuja, Rakhi Maiwall, Archana Rastogi, Veena Malhotra, Ashok Choudhury and Rajeev Khanna and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Journal of Biological Chemistry.

In The Last Decade

Shiv Kumar Sarin

699 papers receiving 21.9k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Diagnosis and management of acute kidney injury in patients with cirrhosis: Revised consensus recommendations of the International Club of Ascites

2015 559 citations Pere Ginès, Shiv Kumar Sarin et al. Journal of Hepatology profile →
World Gastroenterology Organisation Global Guidelines

2014 384 citations Shiv Kumar Sarin et al. profile →
Diagnosis and management of acute kidney injury in patients with cirrhosis: revised consensus recommendations of the International Club of Ascites

2015 379 citations Pere Ginès, Shiv Kumar Sarin et al. Gut profile →
Liver diseases in the Asia-Pacific region: a Lancet Gastroenterology & Hepatology Commission

2019 361 citations Shiv Kumar Sarin, Manoj Kumar et al. profile →
Metabolic (dysfunction)-associated fatty liver disease in individuals of normal weight

2022 156 citations Shiv Kumar Sarin et al. profile →
Carvedilol reduces the risk of decompensation and mortality in patients with compensated cirrhosis in a competing-risk meta-analysis

2022 94 citations Shiv Kumar Sarin, Ankur Jindal et al. Journal of Hepatology profile →
WFUMB Guidelines/Guidance on Liver Multiparametric Ultrasound. Part 2: Guidance on Liver Fat Quantification

2024 42 citations Shiv Kumar Sarin et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Shiv Kumar Sarin	15.8k	15.0k	7.3k	1.9k	1.5k	735	22.6k
Guido Gerken	11.6k 0.7×	11.6k 0.8×	4.9k 0.7×	3.3k 1.7×	1.0k 0.7×	588	23.1k
Dominique Valla	21.0k 1.3×	16.8k 1.1×	9.7k 1.3×	2.1k 1.1×	1.2k 0.8×	487	28.7k
Joan Rodés	23.3k 1.5×	17.8k 1.2×	10.4k 1.4×	1.7k 0.9×	2.4k 1.6×	342	29.4k
Don C. Rockey	8.8k 0.6×	8.3k 0.6×	6.0k 0.8×	2.7k 1.4×	1.0k 0.7×	462	20.0k
Frederik Nevens	9.2k 0.6×	7.8k 0.5×	5.6k 0.8×	2.0k 1.1×	829 0.6×	435	15.4k
Tilman Sauerbruch	7.8k 0.5×	7.5k 0.5×	6.0k 0.8×	1.8k 1.0×	875 0.6×	525	18.6k
Ansgar W. Lohse	12.4k 0.8×	10.8k 0.7×	4.3k 0.6×	1.9k 1.0×	527 0.4×	485	19.5k
Richard K. Sterling	13.7k 0.9×	15.8k 1.1×	4.4k 0.6×	2.1k 1.1×	1.2k 0.9×	326	20.6k
Gideon M. Hirschfield	9.7k 0.6×	11.2k 0.7×	7.8k 1.1×	3.4k 1.8×	561 0.4×	319	23.6k
Antonio Craxı̀	20.4k 1.3×	20.5k 1.4×	2.5k 0.3×	1.4k 0.7×	1.7k 1.2×	519	27.1k

Countries citing papers authored by Shiv Kumar Sarin

Since Specialization

Citations

This map shows the geographic impact of Shiv Kumar Sarin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shiv Kumar Sarin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shiv Kumar Sarin more than expected).

Fields of papers citing papers by Shiv Kumar Sarin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shiv Kumar Sarin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shiv Kumar Sarin. The network helps show where Shiv Kumar Sarin may publish in the future.

Co-authorship network of co-authors of Shiv Kumar Sarin

This figure shows the co-authorship network connecting the top 25 collaborators of Shiv Kumar Sarin. A scholar is included among the top collaborators of Shiv Kumar Sarin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shiv Kumar Sarin. Shiv Kumar Sarin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Sarin, Shiv Kumar, et al.. (2025). Idiopathic Non-Cirrhotic Portal Hypertension and Fibrosis. Current Hepatology Reports. 24(1). 1 indexed citations

Sharma, Aarti, Rajnish Tiwari, Claudia Fuchs, et al.. (2025). Lithocholic acid facilitates release of angiocrine factors by liver sinusoidal endothelial cells during liver regeneration. SHILAP Revista de lepidopterología. 2(1).

Sarin, Shiv Kumar, et al.. (2024). Management of Portal vein Thrombosis in Cirrhosis. Seminars in Liver Disease. 44(4). 416–429. 2 indexed citations

Kulkarni, Anand V. & Shiv Kumar Sarin. (2024). Acute-on-chronic liver failure – steps towards harmonization of the definition!. Journal of Hepatology. 81(2). 360–366. 11 indexed citations

Ahmad, Belal, et al.. (2024). Furanocoumarins promote proteasomal degradation of viral HBx protein and down-regulate cccDNA transcription and replication of hepatitis B virus. Virology. 595. 110065–110065. 4 indexed citations

Kumar, Guresh, et al.. (2024). Ethanol with thioacetamide murine model of alcoholic liver disease identifies hepatic pathways as targets for the human disease. Annals of Hepatology. 30(1). 101565–101565. 1 indexed citations

Sharma, Aarti, Saggere Muralikrishna Shasthry, Guresh Kumar, et al.. (2023). Podoplanin-positive dilated lymphatic vessels in duodenum associates with three-month mortality in patients with cirrhosis. Frontiers in Physiology. 14. 1045983–1045983. 3 indexed citations

Girija, Sanal Madhusudana, et al.. (2023). Hepatitis B Virus x Protein Increases Cellular OCT3/4 and MYC and Facilitates Cellular Reprogramming. Cellular Reprogramming. 25(5). 224–237. 3 indexed citations

Martino, Vincent Di, Delphine Weil, Cornelius Engelmann, et al.. (2023). Granulocyte colony stimulating factor in decompensated cirrhosis, acute alcoholic hepatitis, and acute-on-chronic liver failure: A comprehensive meta-analysis of randomized controlled trials. Clinics and Research in Hepatology and Gastroenterology. 47(9). 102207–102207. 6 indexed citations

10.

Mukund, Amar, et al.. (2023). Percutaneous ablative therapies for hepatocellular carcinoma in the caudate lobe of the liver: efficacy and outcome. British Journal of Radiology. 96(1148). 20220086–20220086. 3 indexed citations

11.

Maiwall, Rakhi, Abhinav Kumar, Samba Siva Rao Pasupuleti, et al.. (2022). A randomized-controlled trial comparing 20% albumin to plasmalyte in patients with cirrhosis and sepsis-induced hypotension [ALPS trial]. Journal of Hepatology. 77(3). 670–682. 49 indexed citations

12.

Caraceni, Paolo, Juan G. Abraldeṣ, Pere Ginès, Philip N. Newsome, & Shiv Kumar Sarin. (2021). The search for disease-modifying agents in decompensated cirrhosis: From drug repurposing to drug discovery. Journal of Hepatology. 75. S118–S134. 39 indexed citations

13.

Varshney, Mohit, et al.. (2020). Initial psychological impact of COVID-19 and its correlates in Indian Community: An online (FEEL-COVID) survey. PLoS ONE. 15(5). e0233874–e0233874. 211 indexed citations

14.

Das, Sukanta, Ashish Kumar Vyas, Meenu Bajpai, et al.. (2019). Hyperoxidized Albumin Modulates Platelets and Promotes Inflammation Through CD36 Receptor in Severe Alcoholic Hepatitis. Hepatology Communications. 4(1). 50–65. 18 indexed citations

15.

Panda, Jiban Jyoti, Avishek Singh, Nitin Yadav, et al.. (2017). Targeted delivery of microRNA‐199a‐3p using self‐assembled dipeptide nanoparticles efficiently reduces hepatocellular carcinoma in mice. Hepatology. 67(4). 1392–1407. 63 indexed citations

16.

Sharma, Barjesh Chander, et al.. (2016). Randomized controlled trial comparing lactulose plus albumin versus lactulose alone for treatment of hepatic encephalopathy. Journal of Gastroenterology and Hepatology. 32(6). 1234–1239. 49 indexed citations

17.

Kumar, Manoj & Shiv Kumar Sarin. (2014). Viral hepatitis eradication in India by 2080 - gaps, challenges & targets. SHILAP Revista de lepidopterología. 4 indexed citations

18.

Sarin, Shiv Kumar, Detlef Schuppan, & Alex P. Mowat. (2002). Announcements. Journal of Hepatology. 36(2). 310–310. 2 indexed citations

19.

Sarin, Shiv Kumar, G K Sachdev, R. Nanda, Surinder K. Batra, & B S Anand. (1986). Comparison of the two time schedules for endoscopic sclerotherapy: a prospective randomised controlled study.. Gut. 27(6). 710–713. 63 indexed citations

20.

Sharma, Manik & Shiv Kumar Sarin. (1985). Ulcerative Colitis in a North Indian Hospital: Current Trends. Journal of the Royal College of Physicians of London. 19(2). 99–102. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact